We are live on ! Find out more
TOV

JLens 500 Jewish Advocacy U.S. ETF

22 hedge funds and large institutions have $41.6M invested in JLens 500 Jewish Advocacy U.S. ETF in 2025 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

47% more funds holding

Funds holding: 1522 (+7)

5.87% less ownership

Funds ownership: 26.21%20.34% (-5.9%)

14% less capital invested

Capital invested by funds: $48.4M → $41.6M (-$6.79M)

Holders
22
Holders Change
+7
Holders Change %
+46.67%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

TOV Hedge Fund Activity: Q4 2025 in Review

22 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in JLens 500 Jewish Advocacy U.S. ETF (TOV) for Q4 2025, worth a combined $41.6M — down 14% from $48.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TOV positions and 3 closed out — a net gain of 7 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was NEPC LLC, adding an estimated $3.51M. The largest seller was Cambridge Associates, cutting an estimated $13M.

  • 22 institutional investors held JLens 500 Jewish Advocacy U.S. ETF (TOV) as of Q4 2025, up from 15 in Q3 2025.
  • Funds reported $41.6M of JLens 500 Jewish Advocacy U.S. ETF stock for Q4 2025, down 14% quarter-over-quarter.
  • 10 funds opened new JLens 500 Jewish Advocacy U.S. ETF positions in Q4 2025 and 3 closed out, a net change of +7 holders.
  • The largest JLens 500 Jewish Advocacy U.S. ETF buyer in Q4 2025 was NEPC LLC, an estimated $3.51M added.
  • The largest JLens 500 Jewish Advocacy U.S. ETF seller in Q4 2025 was Cambridge Associates, an estimated $13M sold.

Based on aggregated 13F filings for Q4 2025.